Echo Therapeutics (ECTE) Posts Narrower Q3 Loss
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Research and development: 588.55K
Today's EPS Names:
ROLR, EROC, ATGN, More
Financial Fact:
Research and development: 588.55K
Today's EPS Names:
ROLR, EROC, ATGN, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.43), versus ($0.49) reported last year. Revenue for the quarter came in at $19.11 million, versus $22.56 million reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Transact Technologies (TACT) Tops Q2 EPS by 1c
- BridgeBio Oncology Therapeutics, Inc. (BBOT) Misses Q2 EPS by 70468c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
